Drug intelligence / Profile preview

miR-145 inhibitor

Development stage
Unknown
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Subcutaneous, Intrathecal, Intravitreal, Inhalation, Intranasal, Intratumoral, Intraperitoneal
01

Overview

A miR-145 inhibitor is a synthetic oligonucleotide, such as an antagomir or a chemically modified antisense strand, designed to specifically bind and neutralize the biological activity of microRNA-145 (miR-145). In various oncological contexts, particularly pancreatic cancer, miR-145 is characterized as a tumor suppressor that downregulates oncogenic targets including Mucin 13 (MUC13), HER2, and AKT. While miR-145 mimics are typically explored for therapeutic restoration of tumor suppression, miR-145 inhibitors are primarily utilized as research tools to investigate the signaling pathways regulated by this microRNA and to model the biological consequences of its downregulation, which is associated with increased cell proliferation, invasion, and metastasis.

Other names
anti-miR-145anti-miR145anti-miR 145antagomir-145antagomir145antagomir 145microRNA-145 inhibitormicroRNA145 inhibitormicroRNA 145 inhibitor

Beyond the preview

Go deeper on miR-145 inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-145 inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call